Microbiological factors that influence the eradication of Helicobacter pylori in adults and children (Q43447254)

23 November 2017

Microbiological factors that influence the eradication of Helicobacter pylori in adults and children (English)

1 reference

23 November 2017

Helicobacter pylori

1 reference

Diego Domingo

1

1 reference

23 November 2017

Teresa Alarcón

2

1 reference

23 November 2017

Alba Edith Vega

3

1 reference

23 November 2017

José Angel García

4

1 reference

23 November 2017

María Josefa Martínez

5

1 reference

23 November 2017

Manuel López-Brea

6

1 reference

23 November 2017

language of work or name

Spanish

0 references

publication date

1 November 2002

1 reference

Infectious Diseases and Clinical Microbiology

23 November 2017

1 reference

23 November 2017

20

1 reference

23 November 2017

9

1 reference

23 November 2017

431-434

1 reference

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

23 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Antibiotic resistance problems with Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

A 9 year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Amino terminus and the first four membrane-spanning segments of the Arabidopsis K+ channel KAT1 confer inward-rectification property of plant-animal chimeric channels

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Prevalence of serum antibodies to Helicobacter pylori VacA and CagA and gastric diseases in Chile

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Virulence factors of Helicobacter pylori in Korean isolates do not influence proinflammatory cytokine gene expression and apoptosis in human gastric epithelial cells, nor do these factors influence the clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Triple therapy with clarithromycin, amoxicillin and omeprazole for Helicobacter pylori eradication in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

The only good Helicobacter pylori is a dead Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

Acid-tolerance response in Helicobacter pylori and differences between cagA+ and cagA- strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972838-3

7 January 2021

10.1016/S0213-005X(02)72838-3

Identifiers

DOI

1 reference

23 November 2017

1 reference